MS SMART -Multiple Sclerosis – Secondary Progressive Multi-Arm Randomisation Trial
Update 1st April 2015 MS-SMART has started and recruitment into the trial will continue through 2015. Two centres are currently…
B Vitamin Promising in Progressive Multiple Sclerosis
Pauline Anderson Washington, DC — A regimen of high doses of biotin, a water-soluble B vitamin, appears to be effective…
Stuart Schlossman
NEWS FLASH for people with PPMS— FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR GENENTECH’S INVESTIGATIONAL MEDICINE OCRELIZUMAB IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
· Ocrelizumab is the first investigational medicine to receive Breakthrough Therapy Designation in multiple sclerosis (MS) · Twelfth Breakthrough Therapy…
Stuart Schlossman
Primary Progressive Multiple Sclerosis (PPMS) Therapeutic Pipeline Review, H2 2015
Primary Progressive Multiple Sclerosis (PPMS) – Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Primary Progressive Multiple Sclerosis (PPMS) –…
Stuart Schlossman
Ocrelizumab Proven Effective In Multiple Sclerosis Treatment for Primary Progressive MS (PPMS)
Successful clinical trial results by Bay Area researchers was released Thursday on a new drug that shows promise to become…
Stuart Schlossman
BREAKING MS NEWS: Genentech’s Ocrelizumab First Investigational Medicine to Show Efficacy in People with Primary Progressive Multiple Sclerosis in Large Phase III Study
Phase III study meets primary endpoint in debilitating form of multiple sclerosis with no approved treatments Ocrelizumab is the first…
Stuart Schlossman
Stem Cells Used to Treat Secondary Progressive Patients in Clinical Trial
What may work better than existing drugs to treat severe multiple sclerosis? Stem cells. A phase 2 clinical study…
Stuart Schlossman
Masitinib Shows Promise in Study For Treating Progressive MS Patients
Masitinib Shows Promise in Study For Treating Progressive MS Patients JULY 24, 2015 Progressive multiple sclerosis patients treated with AB…
Stuart Schlossman
PROGRESSIVE MS – a Sharper Focus
Progressive multiple sclerosis is a form of multiple sclerosis that is characterized as having nerve degeneration (the breakdown…
Stuart Schlossman
MediciNova Announces Update On Phase 2b Trial of MN-166 (Ibudilast) Involving 255 Progressive MS Patients
MediciNova, Inc., a biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet…
Stuart Schlossman
